Company news
Atomo Diagnostics Ltd. (ASX:AT1) news
Every Atomo Diagnostics Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Managing Director & CEO Transition
August 18, 2026
Share Purchase Plan Results
May 15, 2026
Response to ASX Aware Letter
April 17, 2026
Atomo Completes Capital Raise
March 29, 2026
FebriDx FDA CLIA wavier approval unlocks upside for Pascal
March 29, 2026
Trading Halt
March 26, 2026
Pause in Trading
March 25, 2026
Response to ASX Price Query
March 25, 2026
H1 FY26 Results Presentation
February 25, 2026
Appendix 4D and Half Year Report ended 31 Dec 2025
February 25, 2026
Atomo Secures Australian Order for Supply of HIV Self-Tests
February 5, 2026
Atomo Secures a Significant Order for HIV Self-Test
January 29, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 27, 2026
Exclusive Licence for a Novel Liver Function Test on Pascal
January 19, 2026
2025 Appendix 4E and Annual Report
August 28, 2025
Update on Indicated Pascal Supply for FebriDx
August 21, 2025
Successful Placement from Share Purchase Plan Shortfall
August 13, 2025
Atomo secures order for Pascal worth US$410,000 from Lumos
August 6, 2025
Share Purchase Plan Results & Tranche 2 Placement Approved
June 27, 2025
Atomo secures Australian order for supply of HIV Self-Tests
May 26, 2025
Share Purchase Plan Prospectus
May 20, 2025
Atomo completes Capital Raise and undertakes Restructure
April 24, 2025
National Scale up of HIV Self-Test Vending Machines
April 7, 2025
Reinstatement to Quotation
March 24, 2025
Suspension from Quotation
March 24, 2025
H1 FY25 Results Presentation
February 27, 2025
Appendix 4D and Half Year Report ended 31 Dec 2024
February 27, 2025
Atomo Secures Long Term Agreement with Newfoundland
January 13, 2025
Quarterly Activities Report and Appendix 4C
October 28, 2024
Atomo Secures $2.44m Grant to Develop Syphilis Test
October 22, 2024
2024 Appendix 4E and Annual Report
August 28, 2024
Government funded procurement of Atomo HIV tests commencing
June 11, 2024
Significant funding to HIV Self-Testing in Federal Budget
May 15, 2024
AT1 secures significant order for HIV self-tests
April 14, 2024
AT1 secures significant order for HIV self tests for LMIC
March 5, 2024
Appendix 4D and Half Year Report ended 31 Dec 2023
February 25, 2024
Quarterly Activity Report - 31 December 2023
January 28, 2024
Appendix 4C - 31 December 2023
January 28, 2024
Quarterly Activity Report - 30 September 2023
October 25, 2023
Appendix 4C - 30 September 2023
October 25, 2023
HIV Self-Test - Market Update
October 19, 2023
2023 Appendix 4E and Annual Report
August 23, 2023
Quarterly Activity Report - 30 June 2023
July 26, 2023
Appendix 4C - 30 June 2023
July 26, 2023
Investor Presentation - Placement and SPP
July 13, 2023
Atomo Completes Placement and Launches SPP
July 13, 2023
Price Movement Clarification
July 4, 2023
Exclusive Agreement for HIV Testing Signed with Newfoundland
June 14, 2023
Quarterly Activity Report - 31 March 2023
April 26, 2023
Appendix 4C - 31 March 2023
April 26, 2023